BLACKROCK CAPITAL ALLOC TR (BCAT) Fundamental Analysis & Valuation

Q: What is the ChartMill fundamental rating of BLACKROCK CAPITAL ALLOC TR (BCAT) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BCAT.

NYSE:BCAT • US09260U1097

14.83 USD

-0.08 (-0.54%)

At close: Apr 23, 2026

14.85 USD

+0.02 (+0.13%)

After Hours: 4/23/2026, 5:57:21 PM

This BCAT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1. BCAT Profitability Analysis

1.1 Basic Checks

BCAT had positive earnings in the past year.
BCAT had a positive operating cash flow in the past year.
Of the past 5 years BCAT 4 years were profitable.
BCAT had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	11.29%
ROE	13.92%
ROIC	1.78%

ROA(3y)10.46%

ROA(5y)4.2%

ROE(3y)12.08%

ROE(5y)4.75%

ROIC(3y)2.24%

ROIC(5y)2.13%

1.3 Margins

BCAT's Profit Margin has declined in the last couple of years.
BCAT's Operating Margin has improved in the last couple of years.
BCAT's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	63.33%
PM (TTM)	370%
GM	63.33%

OM growth 3Y-1.87%

OM growth 5Y10.43%

PM growth 3YN/A

PM growth 5Y-19.23%

GM growth 3Y-2.65%

GM growth 5Y9.32%

More info and screens

ROA ROE ROIC Operating and Profit Margin Show most profitable peers

2. BCAT Health Analysis

2.1 Basic Checks

The number of shares outstanding for BCAT remains at a similar level compared to 1 year ago.
The number of shares outstanding for BCAT has been reduced compared to 5 years ago.
BCAT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 2.65 indicates that BCAT is not a great score, but indicates only limited risk for bankruptcy at the moment.
There is no outstanding debt for BCAT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	2.65

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

BCAT has a Current Ratio of 0.36. This is a bad value and indicates that BCAT is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.36 indicates that BCAT may have some problems paying its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	0.36
Quick Ratio	0.36

More info and screens

WACC Debt/Equity How to determine the health of a company Altman-Z score Show peers with great health

3. BCAT Growth Analysis

3.1 Past

The Earnings Per Share has grown by an nice 15.22% over the past year.
The Earnings Per Share has been growing by 13.01% on average over the past years. This is quite good.
BCAT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.08%.
Measured over the past years, BCAT shows a very strong growth in Revenue. The Revenue has been growing by 38.13% on average per year.

EPS 1Y (TTM)15.22%

EPS 3YN/A

EPS 5Y13.01%

EPS Q2Q%105.26%

Revenue 1Y (TTM)-23.08%

Revenue growth 3Y-11.69%

Revenue growth 5Y38.13%

Sales Q2Q%-25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks Show best growing peers

4. BCAT Valuation Analysis

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.00, which indicates a rather cheap valuation of BCAT.
BCAT is valuated cheaply when we compare the Price/Earnings ratio to 27.47, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	7
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	4.71
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)0.54

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Price/Earnings Price/FCF FCF per share EV/EBITDA PEG RATIO Show best valued peers

5. BCAT Dividend Analysis

5.1 Amount

With a Yearly Dividend Yield of 19.54%, BCAT is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 1.81, BCAT pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	19.54%

5.2 History

BCAT has been paying a dividend for over 5 years, so it has already some track record.
As BCAT did not decrease their dividend in the past 5 years, we can say the dividend looks stable.

Dividend Growth(5Y)N/A

Div Incr Years3

Div Non Decr Years5

5.3 Sustainability

155.41% of the earnings are spent on dividend by BCAT. This is not a sustainable payout ratio.

DP155.41%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks Show peers with best dividend

BCAT Fundamentals: All Metrics, Ratios and Statistics

BLACKROCK CAPITAL ALLOC TR

NYSE:BCAT (4/23/2026, 5:57:21 PM)

After market: 14.85 +0.02 (+0.13%)

14.83

-0.08 (-0.54%)

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)03-02 2026-03-02

Earnings (Next)N/A N/A

Inst Owners20.27%

Inst Owner Change4.81%

Ins Owners0.04%

Ins Owner Change0%

Market Cap1.55B

Revenue(TTM)60.00M

Net Income(TTM)222.00M

Analysts0

Price TargetN/A

Short Float %0.38%

Short Ratio0.51

Dividend

		Industry Rank	Sector Rank
Dividend Yield	19.54%

Yearly Dividend3.29

Dividend Growth(5Y)N/A

DP155.41%

Div Incr Years3

Div Non Decr Years5

Ex-Date06-15 2026-06-15 (0.2579)

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	7
Fwd PE	N/A
P/S	25.9
P/FCF	4.71
P/OCF	4.71
P/B	0.97
P/tB	0.97
EV/EBITDA	N/A

EPS(TTM)2.12

EY14.3%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)3.15

FCFY21.24%

OCF(TTM)3.15

OCFY21.24%

SpS0.57

BVpS15.23

TBVpS15.23

PEG (NY)N/A

PEG (5Y)0.54

Graham Number26.9548 (81.76%)

Profitability

		Industry Rank	Sector Rank
ROA	11.29%
ROE	13.92%
ROCE	2.25%
ROIC	1.78%
ROICexc	1.78%
ROICexgc	1.78%
OM	63.33%
PM (TTM)	370%
GM	63.33%
FCFM	550%

ROA(3y)10.46%

ROA(5y)4.2%

ROE(3y)12.08%

ROE(5y)4.75%

ROIC(3y)2.24%

ROIC(5y)2.13%

ROICexc(3y)2.25%

ROICexc(5y)2.14%

ROICexgc(3y)2.26%

ROICexgc(5y)2.16%

ROCE(3y)2.84%

ROCE(5y)2.74%

ROICexgc growth 3Y-9.17%

ROICexgc growth 5Y61.97%

ROICexc growth 3Y-8.61%

ROICexc growth 5Y63.08%

OM growth 3Y-1.87%

OM growth 5Y10.43%

PM growth 3YN/A

PM growth 5Y-19.23%

GM growth 3Y-2.65%

GM growth 5Y9.32%

F-Score6

Asset Turnover0.03

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	27.14
Cash Conversion	N/A
Profit Quality	148.65%
Current Ratio	0.36
Quick Ratio	0.36
Altman-Z	2.65

F-Score6

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)139.98%

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)15.22%

EPS 3YN/A

EPS 5Y13.01%

EPS Q2Q%105.26%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-23.08%

Revenue growth 3Y-11.69%

Revenue growth 5Y38.13%

Sales Q2Q%-25%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-26.92%

EBIT growth 3Y-13.34%

EBIT growth 5Y52.55%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-7.04%

FCF growth 3Y-27.55%

FCF growth 5YN/A

OCF growth 1Y-7.04%

OCF growth 3Y-27.55%

OCF growth 5YN/A

BLACKROCK CAPITAL ALLOC TR / BCAT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BLACKROCK CAPITAL ALLOC TR (BCAT) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BCAT.

Can you provide the valuation status for BLACKROCK CAPITAL ALLOC TR?

ChartMill assigns a valuation rating of 2 / 10 to BLACKROCK CAPITAL ALLOC TR (BCAT). This can be considered as Overvalued.

What is the profitability of BCAT stock?

BLACKROCK CAPITAL ALLOC TR (BCAT) has a profitability rating of 3 / 10.

How sustainable is the dividend of BLACKROCK CAPITAL ALLOC TR (BCAT) stock?

The dividend rating of BLACKROCK CAPITAL ALLOC TR (BCAT) is 4 / 10 and the dividend payout ratio is 155.41%.